Literature DB >> 20300754

Lack of evidence for association of two functional SNPs of CHI3L1 gene (HC-gp39) with rheumatoid arthritis.

Sanjeev K Srivastava1, Péter Antal, János Gál, Gábor Hullám, Agnes F Semsei, György Nagy, András Falus, Edit I Buzás.   

Abstract

CHI3L1 gene encodes for a glycoprotein (HC-gp39 or YKL40) secreted by synovial fibroblasts, macrophages, neutrophil granulocytes and chondrocytes. Its expression is under the control of NF-kB. It is regarded as an acute phase protein, and its levels are significantly elevated in rheumatic diseases. Furthermore, HC-gp39 has been shown to be recognized by autoreactive T cells in rheumatoid arthritis. In the present study, we have examined two functional variants of the promoter region of CHI3L1 gene (CHI3L1-1 (rs4950928) and CHI3L1-2 (rs10399931) that have been reported earlier to be associated with schizophrenia and sarcoidosis. We used TaqMan allelic discrimination assays to study the genotypes of Hungarian patients with rheumatoid arthritis (n = 182) and of healthy controls (n = 194). No significant association of the investigated SNPs with the disease was found. Here we report that CHI3L1 SNPs, shown to be involved in the predisposition of schizophrenia, are not associated with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300754     DOI: 10.1007/s00296-010-1396-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  A note on exact tests of Hardy-Weinberg equilibrium.

Authors:  Janis E Wigginton; David J Cutler; Goncalo R Abecasis
Journal:  Am J Hum Genet       Date:  2005-03-23       Impact factor: 11.025

2.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.

Authors:  Robert M Plenge; Chris Cotsapas; Leela Davies; Alkes L Price; Paul I W de Bakker; Julian Maller; Itsik Pe'er; Noel P Burtt; Brendan Blumenstiel; Matt DeFelice; Melissa Parkin; Rachel Barry; Wendy Winslow; Claire Healy; Robert R Graham; Benjamin M Neale; Elena Izmailova; Ronenn Roubenoff; Alexander N Parker; Roberta Glass; Elizabeth W Karlson; Nancy Maher; David A Hafler; David M Lee; Michael F Seldin; Elaine F Remmers; Annette T Lee; Leonid Padyukov; Lars Alfredsson; Jonathan Coblyn; Michael E Weinblatt; Stacey B Gabriel; Shaun Purcell; Lars Klareskog; Peter K Gregersen; Nancy A Shadick; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2007-11-04       Impact factor: 38.330

3.  Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization.

Authors:  J R Connor; R A Dodds; J G Emery; R B Kirkpatrick; M Rosenberg; M Gowen
Journal:  Osteoarthritis Cartilage       Date:  2000-03       Impact factor: 6.576

Review 4.  Rheumatoid arthritis.

Authors:  D M Lee; M E Weinblatt
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

Review 5.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.

Authors:  Y H Lee; Y H Rho; S J Choi; J D Ji; G G Song; S K Nath; J B Harley
Journal:  Rheumatology (Oxford)       Date:  2006-06-07       Impact factor: 7.580

6.  Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes.

Authors:  Anneliese D Recklies; Hua Ling; Chantal White; Suzanne M Bernier
Journal:  J Biol Chem       Date:  2005-10-18       Impact factor: 5.157

7.  Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Gisela Orozco; Elena Sánchez; Miguel A González-Gay; Miguel A López-Nevot; Belén Torres; Rafael Cáliz; Norberto Ortego-Centeno; Juan Jiménez-Alonso; Dora Pascual-Salcedo; Alejandro Balsa; Rosario de Pablo; Antonio Nuñez-Roldan; Maria Francisca González-Escribano; Javier Martín
Journal:  Arthritis Rheum       Date:  2005-01

8.  Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations.

Authors:  Kazuo Yamada; Eiji Hattori; Yoshimi Iwayama; Tomoko Toyota; Tetsuo Ohnishi; Yasuhide Iwata; Kenji J Tsuchiya; Genichi Sugihara; Mitsuru Kikuchi; Yuji Okazaki; Takeo Yoshikawa
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

9.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

10.  A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.

Authors:  Fina A S Kurreeman; Leonid Padyukov; Rute B Marques; Steven J Schrodi; Maria Seddighzadeh; Gerrie Stoeken-Rijsbergen; Annette H M van der Helm-van Mil; Cornelia F Allaart; Willem Verduyn; Jeanine Houwing-Duistermaat; Lars Alfredsson; Ann B Begovich; Lars Klareskog; Tom W J Huizinga; Rene E M Toes
Journal:  PLoS Med       Date:  2007-09       Impact factor: 11.069

View more
  5 in total

1.  Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects.

Authors:  Kaspar R Nielsen; Rudi Steffensen; Martin Boegsted; John Baech; Soeren Lundbye-Christensen; Merete L Hetland; Sophine B Krintel; Hans E Johnsen; Mette Nyegaard; Julia S Johansen
Journal:  Arthritis Res Ther       Date:  2011-06-29       Impact factor: 5.156

2.  Human migration, diversity and disease association: a convergent role of established and emerging DNA markers.

Authors:  Pokhraj Guha; Sanjeev K Srivastava; Soumen Bhattacharjee; Tapas K Chaudhuri
Journal:  Front Genet       Date:  2013-08-09       Impact factor: 4.599

3.  Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.

Authors:  Tuija Väänänen; Katriina Vuolteenaho; Hannu Kautiainen; Riina Nieminen; Timo Möttönen; Pekka Hannonen; Markku Korpela; Markku J Kauppi; Kari Laiho; Oili Kaipiainen-Seppänen; Riitta Luosujärvi; Tea Uusitalo; Toini Uutela; Marjatta Leirisalo-Repo; Eeva Moilanen
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

4.  YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

Authors:  Nicolai A Schultz; Julia S Johansen
Journal:  Cancers (Basel)       Date:  2010-07-12       Impact factor: 6.639

5.  Reverse differentiation as a gene filtering tool in genome expression profiling of adipogenesis for fat marker gene selection and their analysis.

Authors:  Mujib Ullah; Stefan Stich; Thomas Häupl; Jan Eucker; Michael Sittinger; Jochen Ringe
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.